https://www.selleckchem.com/pr....oducts/lonafarnib-sc
In vitro, ASPH targeting by siRNA or SMI reduced cell invasion and growth and caused Notch-1 downregulation. This study demonstrates that ASPH targeting by specific inhibitors could improve CRC treatment strategies.An effective β-nucleating agent for polypropylene crystallization was obtained by the functionalization of reduced graphene oxide with calcium pimelate. The nucleating ability of the modified reduced graphene oxide (rGO-CP) was confirmed during non-isothermal crystallization. In further examinations, the rGO-CP wa
Beğen
Yorum Yap
Paylaş
